ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Gloom and Doom Meeting of docs Turns Hopeful When Patient Offers Health Reform Proposal

February 5, 1993

Drug Development Gets Extra $500,000

November 18, 1977

Another Feasibility Study For Women’s Wealth Trial? Yes And No; It’s ‘Class Of 84’s” Adieu

December 14, 1990

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

NCI To Merge Two Intramural Divisions To Form Center For Cancer Research.

January 12, 2001